mRNA Manufacture

Pro mRNA Manufacture

mRNA GMP Manufacture

The outbreak of COVID-19 has accelerated the development and industrialization of mRNA vaccines. The mRNA vaccine has better transfection efficiency and longer protein expression time, and also avoids the genetic risk of introducing foreign genes. After continuous process development, adjustment and verification, ProBio has established the mRNA manufacturing system, which can synthesize mRNA with different lengths and functions, and uses the LNP delivery system to ensure the quality and stability of mRNA, meeting the different requirements of customers.